Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PDHA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
VWA8-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TMED6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TP53TG3HP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZNF569 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SARDH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ISLR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NACC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSTD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCNX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAS6-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00708 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRHR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZBED5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on